^
Association details:
Biomarker:BRAF V600E
Cancer:Ganglioglioma
Drug:Cotellic (cobimetinib) (MEK1 inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Adjuvant Treatment...Useful in Certain Circumstance...Pilocytic astrocytoma, PXA, ganglioglioma if BRAF V600E activating mutation…cobimetinib